Early Use of a Parkinson's Pump in Advanced Stages
Part of Brain & nervous system clinical trials.
This study tests a new pump-delivered combination of Parkinson's medications (foslevodopa/foscarbidopa) in adults who have recently started having motor fluctuations but are not yet using other device therapies. It aims to see how well it works in real life and may offer better symptom control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease that responds to levodopa medication.
- You are between 18 and 64 years old.
- You have had motor fluctuations (wearing-off of medication) for no more than 3 years.
- Your Parkinson's is still mild when medication is working (Hoehn & Yahr stage under 3).
- You have never used a device-aided therapy (like a pump or brain stimulation) before.
- You must be able to complete a thinking and memory test with a score of 24 or higher.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with Parkinson’s who have troublesome “ups and downs” or involuntary movements, and who need a device/infusion treatment like deep brain stimulation, an apomorphine pump, or a Duodopa pump. It helps doctors see how these second-line treatments are working in real life and what outcomes they produce.
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
This study looks at how well a treatment called foslevodopa/foscarbidopa works for people with advanced Parkinson's disease. It is given as a shot under the skin (subcutaneous) and is already being used in clinics. The study will follow people who are already starting this treatment as part of their regular care.
This study observes how well a new type of levodopa/carbidopa treatment works in real-world practice for people with advanced Parkinson's disease who are already using it. It aims to understand patient experiences and the support program offered by the drug maker.
This study tests an investigational drug to see if it can help people with early Parkinson's disease. It may offer a new treatment option to manage symptoms.
This trial tests a new medication called Lu AF28996 to help reduce the periods when Parkinson's symptoms worsen throughout the day (called 'OFF times'). If you have motor fluctuations that are predictable and affecting your daily life, this study might help you experience fewer of these difficult periods.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.